HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): John M. Kratz James L. Zellner Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bond, B. R. Articles by Spinale, F. G. Search for Related Content PubMed PubMed Citation Articles by Bond, B. R. Articles by Spinale, F. G. Related Collections Cardiac - pharmacology Coronary disease

J Thorac Cardiovasc Surg 2001;122:358-364
© 2001 The American Association for Thoracic Surgery

Cardiopulmonary Support and Physiology (CPS)

Endothelin-1 during and after cardiopulmonary bypass: Association to graft sensitivity and postoperative recovery

From the Department of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, SC.

Supported in part by National Institutes of Health grant HL-45024 (F.G.S.). C.A.W. participated in these studies as a National Medical Fellowships Academic Fellow.

Received for publication April 17, 2000. Revisions requested July 11, 2000; revisions received Dec 4, 2000. Accepted for publication Jan 25, 2001. Address for reprints: Francis G. Spinale, MD, PhD, Medical University of South Carolina, Strom Thurmond Research Building, 114 Doughty St, Suite 625, Charleston, SC 29403.

Abstract

Objective: Our objectives are 2-fold: (1) to serially measure the release of endothelin and graft-conduit endothelin sensitivity during and after coronary artery bypass grafting and (2) to define potential relationships of changes in endothelin levels to perioperative parameters.
Methods: Endothelin plasma content was measured in patients (n = 105) undergoing bypass grafting from select vascular compartments before operations and at specific intervals up to 24 hours postoperatively. Endothelin sensitivity was determined in isolated internal thoracic artery segments.
Results: Systemic arterial and pulmonary arterial endothelin levels were increased by approximately 50% immediately after bypass grafting and increased by another 85% during the first 24 hours postoperatively. Endothelin levels were highest in patients with prolonged ventilatory requirements and extended stays in the intensive care unit (10.2 ± 0.8 vs 13.2 ± 1.1 fmol/mL, P = .02, and 9.8 ± 0.7 vs 13.9 ± 1.2 fmol/mL, P = .01, respectively. Endothelin sensitivity of the internal thoracic artery was increased in patients requiring prolonged vasodilator support with nitroglycerin.
Conclusions: Systemic and pulmonary arterial endothelin levels remained increased for at least 24 hours postoperatively. Prolonged pharmacologic management and increased intensive care unit stay were associated with increased systemic endothelin release and heightened graft-conduit sensitivity to endothelin.

This article has been cited by other articles:

				J. S. Ikonomidis, E. J. Hilton, K. Payne, A. Harrell, L. Finklea, L. Clark, S. Reeves, R. E. Stroud, A. Leonardi, F. A. Crawford Jr, et al. Selective Endothelin-A Receptor Inhibition After Cardiac Surgery: A Safety and Feasibility Study Ann. Thorac. Surg., June 1, 2007; 83(6): 2153 - 2161. [Abstract] [Full Text] [PDF]

				A. Y. Denault, Y. Lamarche, P. Couture, F. Haddad, J. Lambert, J.-C. Tardif, and L. P. Perrault Inhaled milrinone: a new alternative in cardiac surgery? Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 346 - 360. [Abstract] [PDF]

				K. A. Apple, J. E. McLean, C. E. Squires, B. Schaeffer, J. A. Sample, R. L. Murphy, A. M. Deschamps, A. H. Leonardi, C. M. Allen, J. W. Hendrick, et al. Differential Effects of Protein Kinase C Isoform Activation in Endothelin-Mediated Myocyte Contractile Dysfunction With Cardioplegic Arrest and Reperfusion Ann. Thorac. Surg., August 1, 2006; 82(2): 664 - 671. [Abstract] [Full Text] [PDF]

				R. Mukherjee, K. A. Apple, C. E. Squires, B. S. Kaplan, J. E. McLean, S. M. Saunders, R. E. Stroud, and F. G. Spinale Protein Kinase C Isoform Activation and Endothelin-1 Mediated Defects in Myocyte Contractility After Cardioplegic Arrest and Reperfusion Circulation, July 4, 2006; 114(1_suppl): I-308 - I-313. [Abstract] [Full Text] [PDF]

				Z. Xia, K.-H. Kuo, D. V. Godin, M. J. Walker, M. C. Y. Tao, and D. M. Ansley 15-F2t-isoprostane exacerbates myocardial ischemia-reperfusion injury of isolated rat hearts Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1366 - H1372. [Abstract] [Full Text] [PDF]

				A. Ergul, J. S. Johansen, C. Stromhaug, A. K. Harris, J. Hutchinson, A. Tawfik, A. Rahimi, E. Rhim, B. Wells, R. W. Caldwell, et al. Vascular Dysfunction of Venous Bypass Conduits Is Mediated by Reactive Oxygen Species in Diabetes: Role of Endothelin-1 J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 70 - 77. [Abstract] [Full Text] [PDF]

				M. M. Multani, J. S. Ikonomidis, P. Y. Kim, E. A. Miller, K. J. Payne, R. Mukherjee, B. H. Dorman, and F. G. Spinale Dynamic and differential changes in myocardial and plasma endothelin in patients undergoing cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., March 1, 2005; 129(3): 584 - 590. [Abstract] [Full Text] [PDF]

				P. W.M. Fedak, V. Rao, S. Verma, D. Ramzy, L. Tumiati, S. Miriuka, P. Boylen, R. D. Weisel, and C. M. Feindel Combined endothelial and myocardial protection by endothelin antagonism enhances transplant allograft preservation J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 407 - 415. [Abstract] [Full Text] [PDF]

				Z. Xia, J. Gu, D. M. Ansley, F. Xia, and J. Yu Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1404 - 1410. [Abstract] [Full Text] [PDF]

				F. G. Spinale The bioactive peptide endothelin causes multiple biologic responses relevant to myocardial and vascular performance after cardiac surgery J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1031 - 1034. [Full Text] [PDF]

				S. Verma, A. Maitland, R. D. Weisel, P. W. M. Fedak, S.-H. Li, D. A. G. Mickle, R.-K. Li, L. Ko, and V. Rao Increased endothelin-1 production in diabetic patients after cardioplegic arrest and reperfusion impairs coronary vascular reactivity: Reversal by means of endothelin antagonism J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1114 - 1119. [Abstract] [Full Text] [PDF]

				S. Verma, A. Maitland, R. D. Weisel, S.-H. Li, P. W. M. Fedak, N. C. Pomroy, D. A. G. Mickle, R.-K. Li, L. Ko, and V. Rao Hyperglycemia exaggerates ischemia-reperfusion-induced cardiomyocyte injury: Reversal with endothelin antagonism J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1120 - 1124. [Abstract] [Full Text] [PDF]